Related Experiment Videos
Activated CD19+ B cell lamina propria lymphocytes in ulcerative colitis
1Department of Medicine, University of Alberta, Edmonton, Canada.
Immunology and Cell Biology
|August 1, 1993
Summary
B cells in ulcerative colitis (UC) show higher activation markers, including CD71, CD25, and 4F2, compared to Crohn's disease or normal tissues. This suggests increased transitional B cells in UC, potentially linking B cell activation to immunoglobulin differences in inflammatory bowel disease.
Area of Science:
- Immunology
- Gastroenterology
- Cell Biology
Background:
- Isotype differences in immunoglobulin production by lamina propria lymphocytes (LPL) are known in ulcerative colitis (UC) and Crohn's disease (CD).
- B cell activation differences between normal individuals and patients with inflammatory bowel disease (IBD) have not been well-described.
Purpose of the Study:
- To investigate and compare B cell activation in the LPL of patients with UC, CD, and normal controls.
- To explore the relationship between B cell activation status and immunoglobulin production in IBD.
Main Methods:
- Flow cytometry was used to analyze B cell activation markers (CD71, CD25, 4F2) on LPLs.
- Transitional B cells were identified by co-expression of CD45RA and CD45RO.
Main Results:
- UC LPLs exhibited significantly higher expression of CD71, CD25, and 4F2 on CD19+ B cells compared to CD and normal LPLs.
- A greater proportion of transitional B cells (CD45RA+/CD45RO+) was observed in UC LPLs.
- Findings support the role of CD45 isoform transition in CD19 B cell activation.
Conclusions:
- UC LPL B cells display a heightened state of activation compared to those in CD and normal individuals.
- Increased B cell activation in UC may contribute to distinct immunoglobulin production patterns observed in IBD.
- These findings may hold diagnostic and pathophysiological significance for IBD research.